FDA approves oral disease-modifying drug for multiple sclerosis
The FDA recently approved teriflunomide for the treatment of patients with relapsing forms of multiple
sclerosis.
Source: Drug Topics - Clinical News - Category: Drugs & Pharmacology Source Type: news
More News: Drugs & Pharmacology | Multiple Sclerosis